MiR-106a might be an ideal test and evaluation index, and further research on the downstream targeting gene THBS2 might provide a broader approach and method for the diagnosis and treatment of AKI caused by sepsis, the development of molecular targeted drugs and prognosis of sepsis patients. This evidence concerns the gene THBS2 and Sepsis.